.
Abstract The May Measurement Month (MMM) campaign, conducted in South Africa in 2023 aimed to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at university campuses, community centres, schools, sport complexes, public parks, shopping centres, hospitals, and through household visits. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg and/or diastolic BP ≥90mmHg and/or already receiving BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 6,653 were screened, with a mean age of 38.8 years, the majority of whom were females (56.3%). Of all participants, 1,010 (15.2%) reported never having had a BP measured before, 2,500 (37.6%) had hypertension, of whom 1,170 (46.8%) were aware, and 1,098 (43.9%) were on antihypertensive medication. Of those on antihypertensive medication, only 633 (57.7%) had controlled BP, and of all participants with hypertension, only 25.3% had controlled BP. The MMM campaign in South Africa identified a substantial number of participants with untreated or inadequately treated hypertension. The high prevalence of hypertension, despite the young adult age, together with the high proportions of individuals unaware of their hypertension and with uncontrolled BP highlight the importance of hypertension screening and awareness campaigns, and more rigorous management of hypertension, especially among young adults.
Background Preparing medicolegal reports is one of the duties of a physician. The legal procedure is heavily dependent on those reports, which makes them quite significant. it requires expertise and experience to prepare the reports, which essentially describe the severity of the damage. When evaluating radiologic images, physicians may misdiagnose in the absence of these illnesses. This may result to inaccurate medicolegal reports. In order to resolve these conflicts by conducting an entirely new assessment, legal authorities ask for an expert report from a forensic medicine specialist. The presentation aims to demonstrate three cases of individuals who have assessed radiologic images incorrectly. Another goal is to raise forensic medical experts' awareness of these instances. Methods The first case involved a skipped fracture line in the ulna's processus styloideus, the second case included a missed pneumothorax on the right, mosaic attenuation of the lung, and fracture lines in the vertebrae's processus transversus, and the third case involved a skipped fracture line in the pelvic bone's acetabulum, pneumothorax, and mosaic attenuation of the lung. A forensic medicine specialist revised and edited all reports following an additional assessment of the computed tomography and x-rays. Results The goal of forensic medicine specialists' expert reports is to provide assistance in the conduct of justice. Conclusions Developing the assessment of radiologic imaging skills is vital when preparing the expert report. Acknowledgment This presentation was supported by TÜBİTAK BIDEB under the 2224-A International Research Fellowship Program for Participation in Scientific Events Abroad.
Objective: Individuals receiving home health care services often constitute a group with multiple chronic conditions, limited physical mobility, and restricted access to healthcare facilities. Immunization services are therefore critical for preventing infections in this population. Therefore, this study aimed to evaluate the frequency of pneumonia and related hospitalization rates after pneumococcal vaccination in patients receiving home healthcare services. Methods: A retrospective study was conducted at the Home Health Care Unit of Prof. Dr. Cemil Taşcıoğlu City Hospital, by reviewing the records of 125 patients who had received pneumococcal vaccination at home between June and September 2023. For each patient, the number of pneumonia episodes and hospitalization status before and after vaccination were compared. Results: A total of 125 patients were included in the study, consisting of 85 (68.0%) females and 40 (32.0%) males. Regarding age stratification, 9 (7.2%) patients were under 65 years of age, while 116 (92.8%) patients were 65 years of age and older. The mean number of pneumonia episodes decreased significantly from 1.68 ± 1.42 before vaccination to 0.44 ± 0.66 after vaccination, corresponding to an approximately 73.5% reduction (p < 0.001). After vaccination, patients had substantially lower odds of developing pneumonia (matched OR 12.40). A similar improvement was observed in hospitalization rates, which decreased from 17.6% before vaccination to 7.2% afterward (p = 0.019). Hospitalization odds were about threefold lower after vaccination. Conclusion: Our study shows that pneumococcal vaccination among home health care patients was associated with a significant reduction in pneumonia episodes and pneumonia-related hospitalizations. Given the uncontrolled pre–post design, these associations should not be interpreted as direct causal effects. The improvement observed after vaccination suggests that pneumococcal immunization is clinically important for high-risk individuals and should be expanded among similar risk groups. To maximize protection, healthcare providers should routinely screen the immunization status of home healthcare patients and integrate pneumococcal vaccination into standard homecare protocols as a priority preventie measure.
1036 Background: Activating PIK3CA mutations are established oncogenic drivers and predictive biomarkers in MBC. In contrast, PIK3CA amplifications are rare, poorly characterized, and of unclear clinical significance. Tissue-based studies report a prevalence of 1–7%, but their detection and relevance in ctDNA are largely unexplored. Moreover, whether amplifications interact with co-occurring mutations to define a distinct high-risk subset is unknown. We therefore aimed to characterize the impact of PIK3CA amplifications detected in ctDNA through a multi-institutional cohort of patients (pts) with MBC. Methods: This retrospective study analyzed a multi-institutional cohort of 1579 pts with MBC and baseline ctDNA testing with the Guardant360 NGS panel within a large academic consortium (PMAC). Hormone Receptor positivity (HR+) and HER2 status were defined based on the most recent biopsy. Associations between SNVs, CNVs, and clinical characteristics were assessed using multivariable logistic regression. The impact of prognosis, adjusted for the number of prior treatment lines, was evaluated through Cox regression for overall survival (OS), defined from time of baseline ctDNA collection. Results: Among 1,579 pts, 1,121 (71%) were HR+/HER2–, 214 (13.5%) HER2+, and 244 (15.5%) had triple-negative breast cancer (TNBC). PIK3CA CNVs were detected in 7.7% of pts, and 44.7% harbored a concomitant PIK3CA SNVs. PIK3CA CNVs were significantly enriched in TNBC compared with other subtypes (Odds Ratio [OR] 2.02, p=0.011). In the overall population, PIK3CA CNVs were associated with significantly worse OS (HR 2.46, p<0.001), an effect observed across all subtypes, including HR+/HER2– (HR 2.21, p<0.001), HER2+ (HR 5.23, p<0.001), and TNBC (HR 1.81, p=0.018). In multivariable analysis, PIK3CA CNVs remained independently associated with inferior OS in the overall cohort (HR 1.61, p=0.015) and in HR+/HER2– disease (HR 1.38, p=0.048). Notably, the coexistence of a PIK3CA CNV and mutation identified a subset with particularly poor prognosis. Compared with patients harboring PIK3CA SNVs alone, those with concurrent SNVs and CNVs had significantly worse OS in the overall population (HR 1.80, p=0.002), in HR+/HER2– disease (HR 1.51, p=0.037), and in TNBC (HR 5.72, p<0.001). Conclusions: PIK3CA amplifications detected in ctDNA are relatively frequent in MBC and are associated with significantly worse survival across molecular subtypes. The coexistence of PIK3CA amplification and mutation identifies a distinct high-risk subset with particularly poor prognosis, beyond the effect of mutations alone. Further mechanistic understanding and real-world outcome analyses are needed to determine whether PIK3CA amplifications, alone or in combination with mutations, have predictive relevance for response or resistance to PI3K-pathway inhibitors.